Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)
China
· Delayed Price · Currency is CNY 8.35
+0.06 (0.72%)
Apr 30, 2026, 12:54 PM CST
SHE:002566 Revenue
Jilin Jian Yisheng Pharmaceutical had revenue of 178.61M CNY in the quarter ending March 31, 2026, with 12.24% growth. This brings the company's revenue in the last twelve months to 659.66M, up 5.17% year-over-year. In the year 2025, Jilin Jian Yisheng Pharmaceutical had annual revenue of 640.17M, down -4.23%.
Revenue (ttm)
659.66M
Revenue Growth
+5.17%
P/S Ratio
4.16
Revenue / Employee
398.34K
Employees
1,656
Market Cap
2.74B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 640.17M | -28.30M | -4.23% |
| Dec 31, 2024 | 668.47M | -185.20M | -21.69% |
| Dec 31, 2023 | 853.66M | 23.62M | 2.85% |
| Jan 1, 2023 | 830.04M | -47.89M | -5.45% |
| Jan 1, 2022 | 877.93M | 35.34M | 4.19% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Universal Biotech | 1.07B |
| Shandong Sito Bio-technology | 954.76M |
| Hubei Goto Biopharm | 626.28M |
| Shanghai Hile Bio-Technology | 246.35M |
| Cabio Biotech (Wuhan) | 418.18M |
| Suzhou Fushilai Pharmaceutical | 412.51M |
| Guangdong VTR Bio-Tech | 832.26M |
| Jiangsu Sihuan Bioengineering | 344.38M |